Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3FP1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,521
Award facts
- Contract value 100% obligated
- $18,521.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,521.39 to AmerisourceBergen Drug Corp for the supply of DUPIXENT (dupilumab) 300 mg/2 mL pen auto-injectors on January 15, 2026, with completion expected by January 16, 2026. This non-competitive delivery order utilizes a firm fixed-price structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving as a critical vendor for federal medical procurement.
This delivery order is executed under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. DUPIXENT is a specialty biologic medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, reflecting the vendor's role in delivering specialized pharmaceutical commodities across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3FP1?
SPE2DR26F3FP1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F3FP1 worth?
The government has obligated $18,521 on SPE2DR26F3FP1.
Is contract SPE2DR26F3FP1 an order under another contract?
Yes. SPE2DR26F3FP1 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FP1 competed?
The extent of competition for SPE2DR26F3FP1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award